Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03016403
Other study ID # 16-2621.cc
Secondary ID AD-1511-33395
Status Completed
Phase N/A
First received
Last updated
Start date April 3, 2017
Est. completion date July 17, 2020

Study information

Verified date February 2021
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Medically under-served (i.e., low-income, uninsured, underinsured) cancer patients generally encounter significant disparities in accessing care for their mental health needs while undergoing toxic treatments that provide considerable physical and emotional stress. Thus, the investigators propose to adapt evidence-based strategies to a stepped-care intervention model to address the mental health needs of under-served lung cancer (LC) and head and neck cancer (HNC) patients and their caregivers across several levels of symptom severity (e.g., mild, moderate, or severe symptoms of depression and anxiety).


Recruitment information / eligibility

Status Completed
Enrollment 535
Est. completion date July 17, 2020
Est. primary completion date July 17, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility 1. LC and HNC patients: Inclusion Criteria: - Newly diagnosed LC and/or HNC (within a month of recruitment date from the date of 1st visit oncology, Ear Nose and Throat (ENT), or radiation clinic visit/consultation upon pathologic tissue diagnosis; - LC and/or HNC patients at any stage of diagnosis (Stages 0-IV); - Over 18 years old; - English and/or Spanish speaking; - Medically underserved, as defined by at least one or several of the following: 1. Low-income: Below 400% of the 2016 Federal poverty levels; 2. Uninsured: No health insurance (public or private insurance); 3. Underinsured: e.g.: Public insurance (Medicaid, Medicare exclusive, VA); and/or 10% of annual income on out-of-pocket medical expenses for individuals below 200% of the 2016 Federal poverty levels. Exclusion Criteria: - Individuals who do not meet eligibility criteria, including individuals who do not speak English or Spanish; - Those who refuse treatment at one of three hospital sites; - Decisionally-challenged adults with cognitive or personality impairment; - Suicidal ideation, or - Intoxication (alcohol or drugs) that might interfere with their ability to consent or participate in the study; - Individuals from vulnerable populations (e.g., inmates or individuals on probation, - homeless, - pregnant women, and - those with auditory impairment. Note: Individuals who become pregnant or develop auditory impairments after they have been randomized to study condition may remain in the study until completion. 2. Caregivers of LC and/or HNC patients Inclusion Criteria: - Primary caregiver of a newly diagnosed LC and/or HNC patient (per criteria for patients); - Over 18 years old; - English and/or Spanish speaking; - Medically underserved, as defined by at least one or several of the following: 1. Low-income: Below 400% of the 2016 Federal poverty levels; 2. Uninsured: No health insurance (public or private insurance); 3. Underinsured: - (c.1) Public insurance (i.e., Medicaid, Medicare exclusive, VA); - (c.2) 10% of annual income spent on out-of-pocket medical expenses for individuals below 200% of the 2016 Federal poverty level. Exclusion criteria: - Individuals who do not meet eligibility criteria, including individuals who do not speak English or Spanish [at the discretion of the Site Coordinators upon recruitment]; - Caregivers of patients who refuse treatment at one of three hospital sites. - Decisionally challenged adults with: 1. cognitive or personality impairment, 2. suicidal ideation, or 3. intoxication (alcohol or drugs) that might interfere with their ability to consent or participate in the study [at the discretion of the Site Coordinators upon recruitment or the Counselor during the intervention]; - Individuals from: 1. vulnerable populations (e.g., inmates or individuals on probation, homeless, 2. pregnant women, and 3. those with auditory impairment [at the discretion of the Site Coordinators upon recruitment]). 4. Individuals who become pregnant or develop auditory impairments after they have been randomized to study condition may remain in the study until completion.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Stepped-Care Intervention
The intervention delivered evidence-based CBT and stress management across eight counseling sessions.
Enhanced Usual Care
Consists of a list of standard mental health resources offered at the participating hospital, local community, or national non-profit organizations.

Locations

Country Name City State
United States Denver Health Medical Center Denver Colorado
United States National Jewish Health Denver Colorado
United States Saint Joseph Hospital Denver Colorado
United States University of Colorado Denver Denver Colorado
United States Saint Mary's Hospital and Regional Medical Center Grand Junction Colorado

Sponsors (1)

Lead Sponsor Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Symptoms of Depression-Patients Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer (CA) Form v1.0 - Depression (30 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses. 6-months
Primary Symptoms of Anxiety-Patients Patient-Reported Outcomes Measurement Information System, Anxiety (PROMIS-Ca) Form v1.0- Anxiety (22 items). The range of scores is between 8 and 40. The raw scores were used. Higher score corresponds to worse outcome. 6-months
Primary Change in Coping-Patients Coping Self-Efficacy (26 items). Scores can rage from 0 to 260. Higher score corresponds to better outcome. 6-months
Secondary Change in Coping-Caregivers Coping Self-Efficacy (26 items). Higher score corresponds to better outcome. Scores can rage from 0 to 260.
The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.
6-months
Secondary Symptoms of Anxiety-Caregivers PROMIS Form v1.0 - Anxiety (29 items). The range of scores is from 8 to 40. Higher score indicates worse outcome (higher anxiety). Raw scores were used in analyses.
The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.
6-months
Secondary Symptoms of Depression-Caregivers PROMIS Form v1.0 - Depression (28 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses.
The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively.
6-months
Secondary Health-Related Quality of Life-Patients FACT-G version 4 (27 items). The range is 0-108. Higher values indicate better QOL. 6-months
Secondary Perceived Stress-Patients Perceived Stress Scale (PSS) (14 items). The range of scores is 0-40. Higher values indicate higher stress. 6-months
Secondary Perceived Stress-Caregivers Perceived Stress Scale (PSS) (14 items). The range is from 0 to 40. Higher values indicate higher stress. 6-months
Secondary Caregiving Burden-Caregivers Zarit Burden Interview (ZBI) (12 items). The range of scores is 0-48. Higher scores represent higher burden. 6-months
See also
  Status Clinical Trial Phase
Recruiting NCT06152419 - Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project N/A
Recruiting NCT04105647 - Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study N/A
Completed NCT05732350 - Exploratory Drug Interaction Study Between SMIs and DOACs
Active, not recruiting NCT04300244 - Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Phase 2
Recruiting NCT05311709 - Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities Phase 2
Active, not recruiting NCT04396457 - Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901 Phase 2
Recruiting NCT06391749 - Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Not yet recruiting NCT03910283 - Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer N/A
Recruiting NCT03301493 - Genomic Testing and Resulting Medical Decisions
Completed NCT04788147 - Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) N/A
Not yet recruiting NCT06035731 - Evaluation of the Medical Service by Socio-aesthetics in Oncology N/A
Recruiting NCT03274349 - Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma N/A
Recruiting NCT05830097 - A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT02991677 - Exercise Effect on Chemotherapy-Induced Neuropathic Pain N/A
Completed NCT04971304 - Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Recruiting NCT04859400 - Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients N/A
Recruiting NCT05948865 - A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors Phase 1
Recruiting NCT04270890 - Investigation of an Abdominal Compression Device N/A
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A